🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A real mentor is able to give the stage to the mentee

The global inequalities in access to cancer drugs are incredible. 40% of the population does not have access to therapies declared essential by the WHO platinum, taxol...) We are not even talking about IO or targeted therapy. Why? …independientedeoncologia.blogspot.com/2025/01/acceso…

This shouldn't be accepted by the editor!

Resumen en español de artículo publicado en The Lancet Oncology "Principios de Sentido Común en Oncología para el diseño, el análisis y la publicación de Ensayos Clínicos Aleatorizados" …independientedeoncologia.blogspot.com/2025/02/princi…

🎯AI contributes to early detection of BC 🎯AI reduces screen-reading workload 🎯AI doesn't increase false positive rates thelancet.com/journals/landi…

🔴 Targeting tumor metabolism as a potential therapeutic strategy in MTAP-deleted cancer. 🗞️ Recently published in Nature Communications: results from a first-in-human, phase I clinical trial 👉 linke.to/MTAPVHIO_NC #UITM CaixaResearch

Did you know less than 30% of the world's researchers are women? This International Day of Women and Girls in Science, we’re shining a light on Fabíola Costa, Sword's trailblazing Director of Clinical Research, and all the brilliant #WomenInScience shaping the future!

Happy women science day!

2025 is anticipated to be the year with the highest number of phase 3 ADC trials read outs in breast oncology, with impact for all breast cancer subtypes. Here’s 8 ADC breast cancer trials expected to reshape practice in 2025:

Sobretratamiento en pacientes con cáncer al final de la vida. ¿Cuál es el problema? ¿Por qué sucede? ¿Cómo afrontarlo? Resumen en español de esta interesantísima reflexión publicada por ESMO - Eur. Oncology …independientedeoncologia.blogspot.com/2025/02/sobret…

Without TILs expression I don't think we can answer to this question, it's the same as deciding adjuvant chemo in luminal BC without Grade. I consider w the patient the ommission of chemo in pT1bN0 high TILs TNBC.

Register now! 📢 🩺 Webinar by Common Sense Oncology & RioOncology for Spanish-speaking Oncologist 🗣️  Common Sense Oncology principles and their relevance to global oncology. 📅 April 1st 7:30 pm (Madrid-Spain time) Enrique Soto 📍 Zoom event 🔗 Register here: queensu.zoom.us/meeting/regist…

📢How is AI transforming cancer care? Join the Joint ESTRO-ESR Symposium at #ESTRO25 to explore AI’s impact on treatment planning, auto-segmentation, and screening in oncology. ℹ️bit.ly/3QVLxFm 📅 May 5 | ⏰ 15:15-16:30 | 📍 Strauss 1-2 #AIinOncology #RadiationOncology

When academia serves it purpose! Thank you, @ian_tannok, for this brillant appraisal! ascopubs.org/doi/full/10.12…

Pharma members should have never been part of any drug regulatory advisory committee... but there is hope on the horizon.

Don't miss this webrinar where real value (patient centered outcomes/cost) is discussed.

Interesting article navigating unrealistic expectations, clinical trials on terminal patients, and QOL. It's usually "easier" to keep going rather to stop and have difficult and honest conversations, supporting our patients at the end of life.

Amazing work! 👏 AI won't replace doctors but help them, and from a research focus, probably choose those who think out of the box 🤔 nature.com/articles/d4158…

Times are changing... critical sense is setting the bar higher (as it should and for the patient's good)

Not fancy, not a drug! Just a cheap and well organized physical activity program that reduces cancer deaths, and I'm sure also improves metabolic and mental health! Well done 👏